Serum anti-carbonic anhydrase I and II antibodies and idiopathic recurrent pregnancy loss S Caner Karahan, Suleyman Guven, Ahmet Mentese, Aynur Bacak, Muge Kopuz, Mehmet Ozeren Reproductive BioMedicine Online Volume 19, Issue 6, Pages 859-863 (December 2009) DOI: 10.1016/j.rbmo.2009.09.030 Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Anti-carbonic anhydrase I (anti-CA-I) antibodies in sera from women with recurrent pregnancy loss (RPL) and healthy controls. The dotted line indicates the mean value plus 3 SD of healthy control sera (A480=0.463). *=significant difference in comparison of mean±SD value between women with RPL and healthy controls (P<0.05). Reproductive BioMedicine Online 2009 19, 859-863DOI: (10.1016/j.rbmo.2009.09.030) Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 Anti-carbonic anhydrase II (anti-CA-II) antibodies in sera from women with recurrent pregnancy loss (RPL) and healthy controls. The dotted line indicates the mean value plus 3 SD of healthy control sera (A480=0.668). *=significant difference in comparison of mean±SD value between women with RPL and healthy controls (P<0.05). Reproductive BioMedicine Online 2009 19, 859-863DOI: (10.1016/j.rbmo.2009.09.030) Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions
Figure 3 Correlation between anti-CA-I antibody titre and anti-CA-II antibody titre in patients with recurrent pregnancy loss. Dotted lines indicate the mean value+3 SD of healthy control sera absorbance (A480) in both antibodies. Reproductive BioMedicine Online 2009 19, 859-863DOI: (10.1016/j.rbmo.2009.09.030) Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions